Letter

Separation of anxiety and depressive disorders

BMJ 2003; 327 doi: 10.1136/bmj.327.7419.870-a (Published 9 October 2003)
Cite this as: BMJ 2003;327:870.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Authors' reply

  1. Peter Tyrer, head of department (p.tyrer@imperial.ac.uk),
  2. Edward Shorter, professor of the history of medicine
  1. 1Department of Psychological Medicine, Imperial College Faculty of Medicine, St Mary's Campus, London W2 1PD
  2. 2History of Medicine Programme, University of Toronto, Toronto, ON, Canada M5G 1VJ

    EDITOR—Our article merely points to an inefficiency in drug development that seems to be driven by commercial imperatives, and as the targets are phoney diagnoses no advance is made. If we merely promote new indications for old drugs and dump existing compounds when they lose their patents is it surprising that depression and anxiety remain such major causes of morbidity?

    Weeks is right to assert that …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular